These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33171469)

  • 1. Comprehensive Identification of the Human Secretome as Potential Indicators in Treatment Outcome of HPV-Positive and -Negative Cervical Cancer Patients.
    Kong L; Wang J; Cheng J; Zang C; Chen F; Wang W; Zhao H; Wang Y; Wang D
    Gynecol Obstet Invest; 2020; 85(5):405-415. PubMed ID: 33171469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
    Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent prognostic role of human papillomavirus genotype in cervical cancer.
    Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
    BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.
    Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M
    Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
    Kontostathi G; Zoidakis J; Makridakis M; Lygirou V; Mermelekas G; Papadopoulos T; Vougas K; Vlamis-Gardikas A; Drakakis P; Loutradis D; Vlahou A; Anagnou NP; Pappa KI
    Biomed Res Int; 2017; 2017():4180703. PubMed ID: 28261610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
    Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
    J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    Zhang W; Hou T; Niu C; Song L; Zhang Y
    PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
    Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
    J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
    Talieri M; Zoma M; Devetzi M; Scorilas A; Ardavanis A
    Tumour Biol; 2012 Oct; 33(5):1375-83. PubMed ID: 22477710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
    Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
    Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Biomarkers as Promising Predictors of Prognosis in Cervical Cancer Patients.
    Domenici L; Tonacci A; Aretini P; Garibaldi S; Perutelli A; Bottone P; Muzii L; Benedetti Panici P
    Oncology; 2021; 99(9):571-579. PubMed ID: 34265768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
    Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 （LVSI
    Chen CL; Kang S; Chen BL; Yang Y; Guo JX; Hao M; Wang WL; Ji M; Sun LX; Wang L; Liang WT; Wang SG; Li WL; Fan HJ; Liu P; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):589-599. PubMed ID: 32957747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.